Metropolitan Life Insurance CO Sqz Biotechnologies CO Transaction History

Metropolitan Life Insurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$8.93 - $14.85 $64,412 - $107,113	-7,213 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$11.46 - $15.77 $82,660 - $113,749	7,213 New	7,213 $104,000
Q3 2021 Mar 30, 2023	BUY	$11.46 - $15.77 $82,660 - $113,749	7,213 New	7,213 $104,000
Q3 2021 Nov 15, 2021	BUY	$11.46 - $15.77 $82,660 - $113,749	7,213 New	7,213 $104,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.